CliffBio
small molecule

LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER

LEVOFLOXACIN

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameLEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Active ingredientLEVOFLOXACIN
StrengthEQ 250MG/50ML (EQ 5MG/ML)
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJune 2013
Marketing statusRX

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.